Source: Global Legal Chronicle

Concert: Sun Pharmaceutical's $576 Million Acquisition of Concert Pharmaceuticals

Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an [...]

Read full article »
Concert's Competitors | Concert's News | Concert's Financials
Stay up-to-date with the latest news on Concert
Annual Revenue
$100K-5.0M
Employees
25-100
Roger D. Tung's photo - President & CEO of Concert

President & CEO

Roger D. Tung

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Concert